Cardiovascular disease is the leading cause of death both globally and nationally. Type II diabetes poses a major risk factor in the development of cardiovascular disease. New guidelines for cardiovascular disease prevention aim to calculate patients’ ASCVD 10-year risk and treat with statin medication based on risk. This scholarly project aimed to determine if practice change involving education intervention and an emphasis on calculating patient ASCVD 10-year risk would increase the number of diabetic patients on appropriate cholesterol lowering therapy.
